Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Dicot Pharma

0.29 SEK

+0.52 %

Less than 1K followers

DICOT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Dicot Pharma

2019202020212022202320242025
Revenue0.10.2
growth-%91.7 %
EBITDA-13.3-17.5-27.2-31.7-45.0-59.3-82.4
EBIT-13.3-17.5-27.2-31.7-45.0-59.3-82.4
Profit before taxes-13.4-17.5-27.2-31.8-44.2-57.7-80.2
Net income-13.4-17.5-27.2-31.8-44.2-57.7-80.2
EPS-0.32-0.29-0.25-0.13-0.06-0.05-0.04
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-26,433.3 %-19,565.2 %
EBIT-%-26,433.3 %-19,569.6 %
ROE-104.6 %-89.2 %-95.9 %-592.5 %-99.5 %-51.7 %-109.3 %
ROI-95.2 %-81.2 %-85.5 %-256.8 %-82.5 %-46.7 %-93.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.